Paul Ridker

Person

Chestnut Hill, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Polymorphism in the Apo(a) gene predict responsiveness to acetylsal...
- Patent number 11,697,850
- Issue date Jul 11, 2023
- The Brigham & Women's Hospital, Inc.
- Paul M. Ridker
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Relevance of achieved levels of markers of systemic inflammation fo...
- Patent number 11,435,363
- Issue date Sep 6, 2022
- The Brigham & Women's Hospital, Inc.
- Paul M. Ridker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Polymorphism in the Apo(a) gene predict responsiveness to acetylsal...
- Patent number 10,550,433
- Issue date Feb 4, 2020
- The Brigham & Women's Hospital, Inc.
- Paul M. Ridker
- G01 - MEASURING TESTING
Information Patent Grant
Relevance of achieved levels of markers of systemic inflammation fo...
- Patent number 9,164,104
- Issue date Oct 20, 2015
- The Brigham & Women's Hospital, Inc.
- Paul M. Ridker
- G01 - MEASURING TESTING
Information Patent Grant
Inflammatory markers as tools in the detection and prevention of di...
- Patent number 8,101,363
- Issue date Jan 24, 2012
- The Brigham & Women's Hospital, Inc.
- Paul M. Ridker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Systemic inflammatory markers as diagnostic tools in the prevention...
- Patent number 7,964,614
- Issue date Jun 21, 2011
- The Brigham & Women's Hospital, Inc.
- Paul Ridker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Polymorphism in the Apo(a) gene predict responsiveness to acetylsal...
- Patent number 7,943,317
- Issue date May 17, 2011
- The Brigham & Women's Hospital, Inc.
- Paul Ridker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Soluble CD40L(CD154) as a prognostic marker of atherosclerotic dise...
- Patent number 7,189,518
- Issue date Mar 13, 2007
- The Brigham & Women's Hospital, Inc.
- Uwe Schönbeck
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Systematic inflammatory markers as diagnostic tools in the preventi...
- Patent number 7,030,152
- Issue date Apr 18, 2006
- The Brigham & Women's Hospital, Inc.
- Paul Ridker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Systemic inflammatory markers as diagnostic tools in the prevention...
- Patent number 6,040,147
- Issue date Mar 21, 2000
- The Brigham & Women's Hospital, Inc.
- Paul Ridker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
USE OF CANAKINUMAB
- Publication number 20240043525
- Publication date Feb 8, 2024
- Novartis AG
- Georgina BERMANN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION THERAPY FOR CARDIOVASCULAR DISEASES
- Publication number 20210324067
- Publication date Oct 21, 2021
- The Brigham & Women's Hospital, Inc.
- Paul M. Ridker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY FOR CARDIOVASCULAR DISEASES
- Publication number 20200399362
- Publication date Dec 24, 2020
- The Brigham & Women's Hospital, Inc.
- Paul M. Ridker
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
POLYMORPHISM IN THE APO(A) GENE PREDICT RESPONSIVENESS TO ACETYLSAL...
- Publication number 20200248262
- Publication date Aug 6, 2020
- The Brigham & Women's Hospital, Inc.
- Paul M. Ridker
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF CANAKINUMAB
- Publication number 20200239564
- Publication date Jul 30, 2020
- Novartis AG
- Paul RIDKER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF IL-1beta BINDING ANTIBODIES
- Publication number 20190048072
- Publication date Feb 14, 2019
- Novartis AG
- Monica Ligueros-Saylan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
POLYMORPHISM IN THE APO(A) GENE PREDICT RESPONSIVENESS TO ACETYLSAL...
- Publication number 20170335394
- Publication date Nov 23, 2017
- The Brigham & Women's Hospital, Inc.
- Paul M. Ridker
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RELEVANCE OF ACHIEVED LEVELS OF MARKERS OF SYSTEMIC INFLAMMATION FO...
- Publication number 20160266146
- Publication date Sep 15, 2016
- The Brigham & Women's Hospital, Inc.
- Paul M. Ridker
- G01 - MEASURING TESTING
Information Patent Application
POLYMORPHISM IN THE APO(A) GENE PREDICT RESPONSIVENESS TO ACETYLSAL...
- Publication number 20150284799
- Publication date Oct 8, 2015
- Paul M. Ridker
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
POLYMORPHISM IN THE APO(A) GENE PREDICT RESPONSIVENESS TO ACETYLSAL...
- Publication number 20140024623
- Publication date Jan 23, 2014
- CELERA CORPORATION
- Paul M. Ridker
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
POLYMORPHISM IN THE APO(A) GENE PREDICT RESPONSIVENESS TO ACETYLSAL...
- Publication number 20110206667
- Publication date Aug 25, 2011
- The Brigham & Women's Hospital, Inc.
- Paul Ridker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
POLYMORPHISM IN THE APO(A) GENE PREDICT RESPONSIVENESS TO ACETYLSAL...
- Publication number 20090004187
- Publication date Jan 1, 2009
- Paul Ridker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Soluble CD40L (CD 154) as a prognostic marker of atherosclerotic di...
- Publication number 20080058360
- Publication date Mar 6, 2008
- The Brigham & Women's Hospital, Inc.
- Uwe Schonbeck
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Relevance of achieved levels of markers of systemic inflammation fo...
- Publication number 20070292960
- Publication date Dec 20, 2007
- The Brigham & Women's Hospital, Inc.
- Paul Ridker
- G01 - MEASURING TESTING
Information Patent Application
Relevance of achieved levels of markers of systemic inflammation fo...
- Publication number 20060115903
- Publication date Jun 1, 2006
- The Brigham & Women's Hospital, Inc.
- Paul Ridker
- G01 - MEASURING TESTING
Information Patent Application
Systemic inflammatory markers as diagnostic tools in the prevention...
- Publication number 20060104941
- Publication date May 18, 2006
- The Brigham & Women's Hospital, Inc.
- Paul Ridker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method for preventing recurring venous thromboembolism using long-t...
- Publication number 20040235942
- Publication date Nov 25, 2004
- Paul M. Ridker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Soluble CD40L (CD154) as a prognostic marker of atherosclerotic dis...
- Publication number 20030152566
- Publication date Aug 14, 2003
- The Brigham & Women's Hospital, Inc.
- Uwe Schonbeck
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Inflammatory markers as tools in the detection and prevention of di...
- Publication number 20030100486
- Publication date May 29, 2003
- Paul M. Ridker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Paul Ridker

Person

Patents Grantslast 30 patents

Polymorphism in the Apo(a) gene predict responsiveness to acetylsal...

Relevance of achieved levels of markers of systemic inflammation fo...

Polymorphism in the Apo(a) gene predict responsiveness to acetylsal...

Relevance of achieved levels of markers of systemic inflammation fo...

Inflammatory markers as tools in the detection and prevention of di...

Systemic inflammatory markers as diagnostic tools in the prevention...

Polymorphism in the Apo(a) gene predict responsiveness to acetylsal...

Soluble CD40L(CD154) as a prognostic marker of atherosclerotic dise...

Systematic inflammatory markers as diagnostic tools in the preventi...

Systemic inflammatory markers as diagnostic tools in the prevention...

Patents Applicationslast 30 patents

USE OF CANAKINUMAB

COMBINATION THERAPY FOR CARDIOVASCULAR DISEASES

COMBINATION THERAPY FOR CARDIOVASCULAR DISEASES

POLYMORPHISM IN THE APO(A) GENE PREDICT RESPONSIVENESS TO ACETYLSAL...

USE OF CANAKINUMAB

USE OF IL-1beta BINDING ANTIBODIES

POLYMORPHISM IN THE APO(A) GENE PREDICT RESPONSIVENESS TO ACETYLSAL...

RELEVANCE OF ACHIEVED LEVELS OF MARKERS OF SYSTEMIC INFLAMMATION FO...

POLYMORPHISM IN THE APO(A) GENE PREDICT RESPONSIVENESS TO ACETYLSAL...

POLYMORPHISM IN THE APO(A) GENE PREDICT RESPONSIVENESS TO ACETYLSAL...

POLYMORPHISM IN THE APO(A) GENE PREDICT RESPONSIVENESS TO ACETYLSAL...

POLYMORPHISM IN THE APO(A) GENE PREDICT RESPONSIVENESS TO ACETYLSAL...

Soluble CD40L (CD 154) as a prognostic marker of atherosclerotic di...

Relevance of achieved levels of markers of systemic inflammation fo...

Relevance of achieved levels of markers of systemic inflammation fo...

Systemic inflammatory markers as diagnostic tools in the prevention...

Method for preventing recurring venous thromboembolism using long-t...

Soluble CD40L (CD154) as a prognostic marker of atherosclerotic dis...

Inflammatory markers as tools in the detection and prevention of di...